Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

A Shaken Union: Europe’s Economic Struggles and the Prophetic Implications

The Four Horsemen of Europe’s Decline Europe still evokes…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Trump Revokes Obama-Era Climate Rule, Marking Major Shift in Federal Authority

Trump Revokes Obama-Era Climate Rule, Marking Major Shift in…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Rising Tensions With Iran Put Middle East on Edge

Escalating U.S.–Iran tensions threaten Middle East stability…
Read more